bioRxiv

Gene deletion eased osteoarthritis but hindered bone growth in mice

Cartilage-specific gene deletion reduced obesity-associated disease in male and female mice but disrupted bone growth when done early after birth.

Paper by Anupama Binoy, Shadi Moradi, Huanhuan Liu, +12 more authorsShouan Zhu · Ohio University
Knee joints with smooth versus eroded cartilage sit among mice and scattered cells, above shorter disrupted bone and longer bone with orderly growth tissue.

Our read

Mechanisms
Studied:
Preprint: experiments in male and female mice
What changed:
Cartilage-specific gene deletion reduced cartilage damage and pain-related sensitivity in mice with obesity-associated osteoarthritis
The catch:
Pain benefit rests on pain-related sensitivity, a proxy for experienced pain

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Male and female mice developed less obesity-associated osteoarthritis in animal experiments that deleted the gene for acetyl-CoA carboxylase 1, a fat-making enzyme, specifically in cartilage. The deletion reduced cartilage damage and pain-related sensitivity without substantially changing the body’s metabolic responses to a high-fat diet.

After a knee ligament rupture, deletion also reduced pain-related responses, with significant structural protection predominantly in females. Drug-based inhibition of acetyl-CoA carboxylase activity also reduced obesity-worsened osteoarthritis after injury. However, deleting the gene early after birth severely disrupted growth plates, the regions where long bones grow. It impaired the maturation of cartilage cells and reduced bone lengthening, followed by impaired structure in the spongy bone.

Why it matters

Osteoarthritis lacks effective treatments that alter its course. The authors highlight this enzyme as a potential target in adults while emphasizing its essential contribution to normal skeletal growth.

Caveats

Mouse experiments leave open whether targeting this enzyme would reduce joint damage and pain-related symptoms in people. The work is a preprint and has not been peer-reviewed.

Where the evidence stands

Acc inhibitors

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: National Institutes of Health

ACACA

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 7 independent labs in 6 countries
  • 2 trials
  • Funders: National Institutes of Health and 8 more
  • 2 of 2 trials sponsored by developers of drugs aimed at it

Comments

Be the first to comment.

The paper

Acetyl-CoA carboxylase 1 regulates chondrocyte metabolic plasticity with divergent effects on articular cartilage pathology and growth plate development

Anupama Binoy, Shadi Moradi, Huanhuan Liu, +12 more authorsShouan Zhu

Ohio University

bioRxiv, Nov 17, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed

doi.org/10.64898/2026.11.15.766862